You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing inflammation.

The global Bruton Tyrosine Kinase (BTK) Inhibitors market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Bruton Tyrosine Kinase (BTK) Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Bruton Tyrosine Kinase (BTK) Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Bruton Tyrosine Kinase (BTK) Inhibitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
First Generation
Second Generation

Segment by Application
Leukemia
Lymphoma
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Johnson & Johnson and AbbVie (Imbruvica)
AstraZeneca (Calquence)
BeiGene (Zanubrutinib)
InnoCare (Orelabrutinib)
Merck
1 Bruton Tyrosine Kinase (BTK) Inhibitors Market Overview
1.1 Product Overview and Scope of Bruton Tyrosine Kinase (BTK) Inhibitors
1.2 Bruton Tyrosine Kinase (BTK) Inhibitors Segment by Type
1.2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 First Generation
1.2.3 Second Generation
1.3 Bruton Tyrosine Kinase (BTK) Inhibitors Segment by Application
1.3.1 Bruton Tyrosine Kinase (BTK) Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Others
1.4 Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue 2016-2027
1.4.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales 2016-2027
1.4.3 Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027

2 Bruton Tyrosine Kinase (BTK) Inhibitors Market Competition by Manufacturers
2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 Bruton Tyrosine Kinase (BTK) Inhibitors Market Competitive Situation and Trends
2.5.1 Bruton Tyrosine Kinase (BTK) Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bruton Tyrosine Kinase (BTK) Inhibitors Players Market Share by Revenue
2.5.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bruton Tyrosine Kinase (BTK) Inhibitors Retrospective Market Scenario by Region
3.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Bruton Tyrosine Kinase (BTK) Inhibitors Market Facts & Figures by Country
3.3.1 North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country
3.3.2 North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Market Facts & Figures by Country
3.4.1 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country
3.4.2 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region
3.5.2 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Market Facts & Figures by Country
3.6.1 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country
3.6.2 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country
3.7.2 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historic Market Analysis by Type
4.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Type (2016-2021)

5 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historic Market Analysis by Application
5.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Johnson & Johnson and AbbVie (Imbruvica)
6.1.1 Johnson & Johnson and AbbVie (Imbruvica) Corporation Information
6.1.2 Johnson & Johnson and AbbVie (Imbruvica) Description and Business Overview
6.1.3 Johnson & Johnson and AbbVie (Imbruvica) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson & Johnson and AbbVie (Imbruvica) Product Portfolio
6.1.5 Johnson & Johnson and AbbVie (Imbruvica) Recent Developments/Updates
6.2 AstraZeneca (Calquence)
6.2.1 AstraZeneca (Calquence) Corporation Information
6.2.2 AstraZeneca (Calquence) Description and Business Overview
6.2.3 AstraZeneca (Calquence) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AstraZeneca (Calquence) Product Portfolio
6.2.5 AstraZeneca (Calquence) Recent Developments/Updates
6.3 BeiGene (Zanubrutinib)
6.3.1 BeiGene (Zanubrutinib) Corporation Information
6.3.2 BeiGene (Zanubrutinib) Description and Business Overview
6.3.3 BeiGene (Zanubrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BeiGene (Zanubrutinib) Product Portfolio
6.3.5 BeiGene (Zanubrutinib) Recent Developments/Updates
6.4 InnoCare (Orelabrutinib)
6.4.1 InnoCare (Orelabrutinib) Corporation Information
6.4.2 InnoCare (Orelabrutinib) Description and Business Overview
6.4.3 InnoCare (Orelabrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 InnoCare (Orelabrutinib) Product Portfolio
6.4.5 InnoCare (Orelabrutinib) Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck Product Portfolio
6.5.5 Merck Recent Developments/Updates

7 Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturing Cost Analysis
7.1 Bruton Tyrosine Kinase (BTK) Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bruton Tyrosine Kinase (BTK) Inhibitors
7.4 Bruton Tyrosine Kinase (BTK) Inhibitors Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bruton Tyrosine Kinase (BTK) Inhibitors Distributors List
8.3 Bruton Tyrosine Kinase (BTK) Inhibitors Customers

9 Bruton Tyrosine Kinase (BTK) Inhibitors Market Dynamics
9.1 Bruton Tyrosine Kinase (BTK) Inhibitors Industry Trends
9.2 Bruton Tyrosine Kinase (BTK) Inhibitors Growth Drivers
9.3 Bruton Tyrosine Kinase (BTK) Inhibitors Market Challenges
9.4 Bruton Tyrosine Kinase (BTK) Inhibitors Market Restraints

10 Global Market Forecast
10.1 Bruton Tyrosine Kinase (BTK) Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bruton Tyrosine Kinase (BTK) Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Bruton Tyrosine Kinase (BTK) Inhibitors by Type (2022-2027)
10.2 Bruton Tyrosine Kinase (BTK) Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bruton Tyrosine Kinase (BTK) Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Bruton Tyrosine Kinase (BTK) Inhibitors by Application (2022-2027)
10.3 Bruton Tyrosine Kinase (BTK) Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bruton Tyrosine Kinase (BTK) Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Bruton Tyrosine Kinase (BTK) Inhibitors by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 105